Parallel hybridization analysis of multiple protein kinase genes: Identification of gene expression patterns characteristic of human hepatocellular carcinoma

Genomics

Volumn 50, Issue 3, 1998, Pages 331-340

  Tsou, Ann Ping ^a   Wu, Keh Ming ^a   Tsen, Ten Yen ^a   Chi, Chin Wen ^b   Chiu, Jen Hwey ^a,b   Lui, Wing Yiu ^b   Hu, Cheng Po ^b   Chang, Chungming ^a,c   Chou, Chen Kung ^b   Tsai, Shih Feng ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cancer; Expression; Gene; Hybridization; Kinase; Liver

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RNA;

ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SEQUENCE; GENE EXPRESSION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION;

EID: 0032526475     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5338     Document Type: Article

References (39)

1. Aden D. P., Fogel A., Plotkin S., Damjanov I., Knowles B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 282:1979;615-616.
2. Adnane J., Gaudray P., Dionne C. A., Crumley G., Jaye M., Schlessinger J., Janteur P., Birnbaum D., Theillet C. BEK and FLG, two receptors of the FGF family, are amplified in subsets of human breast cancers. Oncogene. 6:1991;659-663.
3. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
4. Blank J. L., Gerwins P., Elliott E. M., Sather S., Johnson G. L. Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. J. Biol. Chem. 271:1996;5361-5368.
5. Carter T. H., Kung H. J. Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor. Crit. Rev. Oncogenesis. 5:1994;389-428.
6. Chang C., Lin Y., O-Lee T. W., Chou C. K., Lee T. S., Liu T. J., P'eng F. K., Chen T. Y., Hu C. P. Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol. Cell. Biol. 6:1983;1133-1137.
7. Chang M. H., Chen C. J., Lai M. S., Hsu H. M., Wu T. C., Kong M. S., Liang D. C., Shau W. Y., Chen D. S. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N. Engl. J. Med. 336:1997;1855-1859.
8. Chesi M., Nardini E., Brents L. A., Shrock E., Ried T., Kuehl W. M., Bersagel P. L. Frequent translocation t94;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat. Genet. 16:1997;260-264.
9. Fridell Y-W. C., Jin Y., Quilliam L. A., Burchert A., McCloskey P., Spizz G., Varnum B., Der C., Liu E. T. Differential activation of the ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol. Cell. Biol. 16:1996;135-145.
10. van der Geer P., Hunter T. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10:1994;251-337.
11. Goruppi S., Ruaro E., Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 firbroblasts. Oncogene. 12:1996;471-480.
12. Hanks S. K., Hunter T. The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification. FASEB J. 9:1995;576-596.
13. Hermansson M., Nister M., Betsholtz C., Heldin C. H., Westermark B., Funa K. Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc. Natl. Acad. Sci. USA. 85:1988;7748-7752.
14. Hershberger C. L., Larson J. L., Arnold B., Rosteck P. R. Jr., Williams P., Dehoff B., Dunn P., O'Neal K. L., Riemen M. W., Tice P. A., Crofts R., Ivancic J. A cloned gene for human transferrin. Ann. N. Y. Acad. Sci. 646:1991;140-154.
15. Hunter T. Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling. Cell. 80:1995;225-236.
16. Ing Y. L., Leung I. W. L., Heng H. H. Q., Tsui L-C., Lassam N. J. MLK-3: Identification of a widely-expressed protein kinase bearing an SH3 domain and a leucine zipper-basic region domain. Oncogene. 9:1994;17445-11750.
17. Knowles B. B., Howe C. C., Aden D. P. Human hepatocellular carcinoma cell lines secret the major plasma protein and hepatitis B surface antigen. Science. 209:1980;497-499.
18. Kobrin M. S., Yamanaka Y., Friess H., Lopez M. E., Korc M. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res. 53:1993;4741-4744.
19. Leung H. Y., Gullick W. J., Lemoine N. R. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int. J. Cancer. 59:1994;667-675.
20. Mills J. J., Jirtle R. L., Boyer I. J. Mechanisms of liver tumor promotion. Liver Regeneration and Carcinogenesis. 1995;Academic Press, New York. p. 199-218.
21. Morrison R. S., Yanaguchi F., Bruner J. M., McKeehan W., Berger M. S. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforms. Cancer Res. 54:1994;2794-2799.
22. Mossie K., Jallal B., Alves F., Sures I., Plowman G. D., Ullrich A. Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. Oncogene. 11:1995;2179-2184.
23. Nakabayashi H., Taketa K., Miyano K., Yamane T., Sato J. Growth of human hepatoma cell lines with different functions in chemically defined medium. Cancer Res. 42:1982;3858-3863.
24. Vital Health Stat. 2:1992;90-91.
25. O'Bryan J. P., Frye R. A., Cogswell P. C., Neubauer A., Kitch B., Prokop C., Espinosa R. III, Le Beau M. M., Earp H. S., Lieu E. T. Axl. Mol. Cell. Biol. 11:1991;5016-5031.
26. Ogasawara S., Yano H., Iemura A., Hisaka T., Kojiro M. Expression of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines. Hepatology. 24:1996;198-205.
27. Perlmutter R. M., Marth J. D., Lewis D. B., Peet R., Ziegler S. F., Wilson C. B. Structure and expression of lck transcripts in human lymphoid cells. J. Cell Biochem. 38:1988;117-126.
28. Quintrell N., Lebo R., Varmus H., Bishop J. M., Pettenati M. J., Le Beau M. M., Diaz M. O., Rowley J. D. Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells. Mol. Cell. Biol. 7:1987;2267-2275.
29. Robinson D., He F., Pretlow T., Kung H-J. A tyrosine kinase profile of prostate carcinoma. Proc. Natl. Acad. Sci. USA. 93:1996;5958-5962.
30. Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu. Science. 235:1987;177-182.
31. Slamon D. J., Press M. F., Godolphin W., Ramos L., Haran P., Shek L., Stuart S. G., Ullrich A. Studies of the HER-2/neu. Furth M., Greaves M. Cancer Cells 7: Molecular Diagnostics of Human Cancer. 1989;371-384 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
32. Stitt T. N., Conn G., Gore M., Lai C., Bruno J., Radziejewski C., Mattsson K., Fisher J., Gles D. R., Jones P. F., Masiakowski P., Ryan T. E., Tobkes N. J., Chen D. H., DiStefano P. S., Long G. L., Basilico C., Goldfarb M. P., Lemke G., Glass D. J., Yancopoulos G. D. The anticoagulation factor protein S and its relative, Gas6, are ligands for the tyro 3/axl family of receptor tyrosine kinases. Cell. 80:1995;661-670.
33. Theillet C., Adelaide J., Louason G., Bonnet-Dorion F., Jacquemier J., Adnane J., Longy M., Katsaros D., Sismondi P., Gaudray P., Birnbaum D. FGFR1 and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers. Genes Chromosomes Cancer. 7:1993;219-226.
34. Tibbles L. A., Ing Y. L., Kiefer F., Chan J., Iscove N., Woodget J. R., Lassam N. J. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J. 15:1996;7026-7035.
35. Varnum B. C., Young C., Elliott G., Garcia A., Bartley T. D., Fridell Y-W., Hunt R. W., Trail G., Clogston C., Toso R. J., Yanaglhara D., Bennett L., Sylber M., Merewether L. A., Tseng A., Escobar E., Liu E. T., Yamane H. K. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature. 373:1995;623-626.
36. Wang J., Coltera M. D., Gown A. M. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: An immunohistochemical and in situ hybridization study. Cancer Res. 54:1994;560-564.
37. Webster M. K., Donoghue D. J. FGFR activation in skeletal disorders: Too much of a good thing. Trends Genet. 13:1997;178-182.
38. Zehetner G., Lehrach H. The reference library system - Sharing biological material and experimental data. Nature. 367:1994;489-491.
39. Ziegler S. F., Marth J. D., Lewis D. B., Perlmutter R. M. Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin. Mol. Cell. Biol. 7:1987;2276-2285.